MedTrace Logo

Sentinel Lymph Node Total Tumoral Load as a Predictor of Non Sentinel Node Involvement in Early Breast Cancer

NCT01669265 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 701

Last updated 2014-11-18

No results posted yet for this study

Summary

This is a retrospective, multicentric cohort study of patient cases with cT1-3, N0 early breast cancer, who previously had intraoperative sentinel lymph node (SLN) evaluation by one-step nucleic acid amplification (OSNA) assay with a complete axillary dissection.

The aim of the present study is to assess the intraoperative positive SLN total tumor load (TTL) obtained from the OSNA assay and to determine whether this TTL predicts non-SLN metastasis in patients with clinically node-negative early-stage breast cancer.

Conditions

Sponsors & Collaborators

  • Sysmex America, Inc.

    collaborator INDUSTRY

  • SOLTI Breast Cancer Research Group

    lead OTHER

Principal Investigators

  • Vicente Peg, MD · Vall d´Hebron University Hospital

  • Isabel Rubio, MD, PhD · Vall d´Hebron University Hospital

  • Martin Espinosa-Bravo, MD, PhD · Vall d´Hebron University Hospital

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2012-06-30
Completion
2012-08-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01669265 on ClinicalTrials.gov